SCHEMBL6684430

SCHEMBL6684430

CC(=O)COc1ccc(N)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.54
TSHR P16473 1/20 0.54
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
PARP10 Q53GL7 2/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2012826 0.98 TDP1 (0.52) TDP1TSHRRAB9ASMN1; SMN2NPC1
SCHEMBL2955123 0.89 HPGD (0.50) RAB9ASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL11577395 0.85 TDP1 (0.47) TDP1TSHRRAB9ASMN1; SMN2NPC1
SCHEMBL29158551 0.83 TDP1 (0.46) TDP1TSHRRAB9ASMN1; SMN2NPC1
Calcium SCHEMBL30753806 0.83 TDP1 (0.46) TDP1TSHRRAB9ASMN1; SMN2NPC1
SCHEMBL9811886 0.83 MEN1 (0.50) TDP1RAB9ATP53ALDH1A1KDM4E
SCHEMBL17676526 0.83 TDP1 (0.52) TDP1TSHRRAB9ASMN1; SMN2NPC1
SCHEMBL2185554 0.81 TAAR1 (0.53) MAOB
SCHEMBL10858118 0.81 LMNA (0.58) RAB9ASMN1; SMN2NPC1ALDH1A1KDM4E
SCHEMBL3999558 0.81 TDP1 (0.51) TDP1TSHRRAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108774150-A Purification process, device and its gained purified product of 2- nitro -4- acetyl-anisidines 宁夏中盛新科技有限公司 2018-11-09 CN claimed
CN-105949949-B Wear-resistant epoxy coating that a kind of blade of wind-driven generator uses and preparation method thereof 广发惠东风电有限公司 2018-05-11 CN claimed
CN-106866449-B A kind of method that the acetyl-anisidine of 2 amino 4 is prepared using 2,4 dinitrophenol hydrogenating reduction by-product recoveries 九江善水科技股份有限公司 2018-01-05 CN claimed
CN-107286036-A The preparation method of 4- acetyl-anisidines 烟台安诺其精细化工有限公司 2017-10-24 CN claimed
CN-106866449-A A kind of method that the acetyl-anisidine of 2 amino 4 is prepared using 2,4 dinitrophenol hydrogenating reduction by-product recoveries 九江善水科技股份有限公司 2017-06-20 CN claimed
CN-106608838-A Production technology of 2-amino-4-acetyl amino phenyl methyl ether 宁夏际华环境安全科技有限公司 2017-05-03 CN claimed
CN-102344381-B Preparation method for byproduct scarlet base RC of red base B JIANGSU LIDANING CHEMICAL CO LTD 2014-05-28 CN claimed
US-11760775-B2 Steroids and protein-conjugates thereof REGENERON PHARMACEUTICALS, INC. 2023-09-19 US disclosed
CN-115710559-A Methods and compositions for improving corn yield 新叶共生有限公司 2023-02-24 CN disclosed
US-20210040144-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. 2021-02-11 US disclosed
US-10711032-B2 Steroids and protein-conjugates thereof REGENERON PHARMACEUTICALS, INC. (US) 2020-07-14 US disclosed
CN-106536652-B Coating composition 关西涂料株式会社 2019-08-16 CN disclosed
CN-109608355-A A kind of synthesis technology of 2- amino -4- acetyl-anisidine 浙江闰土新材料有限公司 2019-04-12 CN disclosed
CN-102190927-A Ink set and recording method using the same SEIKO EPSON CORP 2011-09-21 CN disclosed
CN-101981138-A Cathodic electrodeposition coatings containing polymethylene urea BASF COATINGS AG 2011-02-23 CN disclosed
CN-101374920-B Aqueous intermediate coating composition and method for forming multilayer coating film KANSAI PAINT CO LTD 2011-02-09 CN disclosed
CN-101407688-A Water-based paint compositions KANSAI PAINT CO LTD (JP) 2009-04-15 CN disclosed
CN-101374920-A Aqueous intermediate coating composition and method for forming multilayer coating film KANSAI PAINT CO LTD (JP) 2009-02-25 CN disclosed
WO-2004069145-A2 ANTICANCER COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2004-08-19 WO disclosed
CN-1137285-A Novel fluoran compound, intermediate, and chromogenic recording material NIPPON SODA CO (JP) 1996-12-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10711032-B2 Steroids and protein-conjugates thereof SERPINA6, NR3C1, NR3C2 TDP1 4502/4885TSHR 761/4885RAB9A 2558/4885
US-20210040144-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF SERPINA6, NR3C1, NR3C2 TDP1 4455/4885TSHR 809/4885RAB9A 2616/4885
US-11760775-B2 Steroids and protein-conjugates thereof SERPINA6, NR3C1, NR3C2 TDP1 4455/4885TSHR 809/4885RAB9A 2616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.